The Latest News from IDF

IDF Europe announces new partnerships

The International Diabetes Federation European Region (IDF Europe) announced the conclusion of two Corporate Partnerships with pharmaceutical company Janssen and medical devices company Ypsomed.

Appointment of interim CEO of IDF

Linda McGoldrick has been appointed interim Chief Executive Officer of IDF until a permanent appointment is made, hopefully by the spring of 2013.

Linda is a global business strategy leader and policy expert in the health care and life sciences sectors.  She has held a number of senior roles in European and North American companies, and has extensive experience of serving on the boards of NGOs, charities and public bodies in both Europe and the US.

LFAC partner donates one million test strips to the Programme

As part of its World Diabetes Day 2012 celebrations, IDF Life for a Child Programme partner LifeScan, Inc., part of the Johnson & Johnson Family of Diabetes Companies, has generously donated one million test strips to children with diabetes in seven countries (Mali, Zimbabwe, Bangladesh, Nepal, Sri Lanka, Guyana, Guatemala) supported by the Programme.

Driving NCD awareness forward in Uganda

The Uganda Non-Communicable Disease Alliance (UNCDA) has taken a major step towards advancing a scalable model of integrated community screening and treatment for NCDs. On Saturday, 15 December, UNCDA and key partners organized the first ever Patient Empowerment Day for NCDs.

LFAC announces formation of Medical & Scientific Advisory Group

The International Diabetes Federation’s Life for a Child Programme is pleased to formally announce the formation of the Life for a Child Medical & Scientific Advisory Group. Composed of International and Country Advisors, the Group’s primary function will be to support the Programme in achieving its vision that “No child should die of diabetes”. Over a two year term (2012-14), advisors will:

Call for Youth Leadership Camp venue

For the 3rd edition of its Youth Leadership Camp to be organized during the summer of 2013, IDF Europe has published a call for European Diabetes Associations to propose a camp venue.

World Guide to IDF Bridges 2012

The IDF BRIDGES programme supports translational research to determine the actions that improve outcomes in different populations. To date, BRIDGES is supporting 38 studies into sustainable community-based interventions for adoption in the real world.  The programme is active in 34 countries worldwide, from Belfast to Bamako, Melbourne to Amman.

Donation helps children with diabetes in Eritrea

Cordis EMEA, part of the Johnson & Johnson family of companies, has donated 2,610EUR to the IDF Life for a Child programme. This generous donation was raised during the congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Part of the funds will go toward helping the lives of children with diabetes in Eritrea through the Eritrea National Diabetic Association, a partner of the Life for a Child programme. Meters and one year's worth of strips will be provided for around 45 children and youth in the country.

EMA recommends approval of higher-strength insulin

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommanded to give marketing authorisation to insulin degludec, a new basal analogue insulin for the treatment of diabetes mellitus in adults. It is introduced in a pre-filled pen in two formulations – 100 units/ml and 200 units/ml.

IDF Europe Newsletter, World Diabetes Day issue

The new IDF Europe Quarterly newsletter is here! In this special World Diabetes Day issue, you will find out about all the activities organized throughout Europe to celebrate this very special date for people living with diabetes.